symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
TCBP,0.4101,0,389360,3320822,0,0.33-12.0,-0.002,TC Biopharm (Holdings) Plc,USD,0001872812,US87807D1037,87807D103,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.tcbiopharm.com,"TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.",Mr. Bryan L. Kobel,Healthcare,GB,60,44 14 1433 7557,Maxim 1,Motherwell,,ML1 4WR,,0,https://financialmodelingprep.com/image-stock/TCBP.png,2022-02-11,False,False,True,False,False
